Demethyleneberberine: A possible treatment for Huntington’s disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Demethyleneberberine: A possible treatment for Huntington’s disease
Authors
Keywords
Huntington disease, Demethyleneberberine, Reactive oxygen/nitrogen species, Oxidative stress, Neuroinflammation
Journal
MEDICAL HYPOTHESES
Volume 153, Issue -, Pages 110639
Publisher
Elsevier BV
Online
2021-06-30
DOI
10.1016/j.mehy.2021.110639
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhanced oral bioavailability and neuroprotective effect of fisetin through its SNEDDS against rotenone-induced Parkinson's disease rat model
- (2020) Rajan Kumar et al. FOOD AND CHEMICAL TOXICOLOGY
- Multiple target-based combination therapy of galantamine, memantine and lycopene for the possible treatment of Alzheimer’s disease
- (2020) Sukriti Vishwas et al. MEDICAL HYPOTHESES
- Exploring role of probiotics and Ganoderma lucidum extract powder as solid carriers to solidify liquid self-nanoemulsifying delivery systems loaded with curcumin
- (2020) Rubiya Khursheed et al. CARBOHYDRATE POLYMERS
- Therapeutic potential of mushrooms in diabetes mellitus: Role of polysaccharides
- (2020) Rubiya Khursheed et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations
- (2020) Sukriti Vishwas et al. Current Neuropharmacology
- Self-nanoemulsifying drug delivery system of fisetin: Formulation, optimization, characterization and cytotoxicity assessment
- (2019) Rajan Kumar et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Solid self-nanoemulsifying drug delivery systems for oral delivery of polypeptide-k: Formulation, optimization, in-vitro and in-vivo antidiabetic evaluation
- (2017) Varun Garg et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Quantification of huntingtin protein species in Huntington’s disease patient leukocytes using optimised electrochemiluminescence immunoassays
- (2017) Davina J. Hensman Moss et al. PLoS One
- Phytochemicals That Regulate Neurodegenerative Disease by Targeting Neurotrophins: A Comprehensive Review
- (2015) Ramu Venkatesan et al. Biomed Research International
- Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model
- (2015) Wenxiao Jiang et al. PLoS One
- Berberine Protects against Neuronal Damage via Suppression of Glia-Mediated Inflammation in Traumatic Brain Injury
- (2014) Chien-Cheng Chen et al. PLoS One
- The Role of the Immune System in Huntington’s Disease
- (2013) Gisa Ellrichmann et al. Clinical & Developmental Immunology
- Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53/cyclin D1 and PI3K/Akt
- (2013) Yu-Shuang Chai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: Up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability
- (2012) Xiaolin Zhang et al. BRAIN RESEARCH
- Bererine induces peripheral lymphocytes immune regulations to realize its neuroprotective effects in the cerebral ischemia/reperfusion mice
- (2012) Bing Song et al. CELLULAR IMMUNOLOGY
- Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases
- (2012) Mahesh Ramalingam et al. JOURNAL OF NEURAL TRANSMISSION
- Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways
- (2012) Liyun Jia et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model
- (2012) Siva Sundara Kumar Durairajan et al. NEUROBIOLOGY OF AGING
- Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms
- (2011) Hong-mei Li et al. ACTA PHARMACOLOGICA SINICA
- PI3K p55γ promoter activity enhancement is involved in the anti-apoptotic effect of berberine against cerebral ischemia–reperfusion
- (2011) Jun Hu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Huntington's disease: a clinical review
- (2011) Raymund A.C. Roos Orphanet Journal of Rare Diseases
- Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides
- (2010) Qian Zhang et al. FOOD AND CHEMICAL TOXICOLOGY
- Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia
- (2010) Dah-Yuu Lu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Excitotoxicity of TNFα derived from KA activated microglia on hippocampal neurons in vitro and in vivo
- (2010) Wei Zhu et al. JOURNAL OF NEUROCHEMISTRY
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- Mitochondria in Huntington's disease
- (2009) Maria Damiano et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Tramadol-Induced Seizurogenic Effect: A Possible Role of Opioid-Dependent γ-Aminobutyric Acid Inhibitory Pathway
- (2008) Ashish K. Rehni et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Neuroprotective effects of berberine on stroke models in vitro and in vivo
- (2008) Xi-Qiao Zhou et al. NEUROSCIENCE LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now